Literature DB >> 23360174

More than cell dust: microparticles isolated from cerebrospinal fluid of brain injured patients are messengers carrying mRNAs, miRNAs, and proteins.

Silke Patz1, Christa Trattnig, Gerda Grünbacher, Birgit Ebner, Christian Gülly, Alexandra Novak, Beate Rinner, Gerd Leitinger, Markus Absenger, Oana A Tomescu, Gerhard G Thallinger, Ulrike Fasching, Sonja Wissa, Juan Archelos-Garcia, Ute Schäfer.   

Abstract

Microparticles are cell-derived, membrane-sheathed structures that are believed to shuttle proteins, mRNA, and miRNA to specific local or remote target cells. To date best described in blood, we now show that cerebrospinal fluid (CSF) contains similar structures that can deliver RNAs and proteins to target cells. These are, in particular, molecules associated with neuronal RNA granules and miRNAs known to regulate neuronal processes. Small RNA molecules constituted 50% of the shuttled ribonucleic acid. Using microarray analysis, we identified 81 mature miRNA molecules in CSF microparticles. Microparticles from brain injured patients were more abundant than in non-injured subjects and contained distinct genetic information suggesting that they play a role in the adaptive response to injury. Notably, miR-9 and miR-451 were differentially packed into CSF microparticles derived from patients versus non-injured subjects. We confirmed the transfer of genetic material from CSF microparticles to adult neuronal stem cells in vitro and a subsequent microRNA-specific repression of distinct genes. This first indication of a regulated transport of functional genetic material in human CSF may facilitate the diagnosis and analysis of cerebral modulation in an otherwise inaccessible organ.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23360174     DOI: 10.1089/neu.2012.2596

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  31 in total

1.  Microparticles impact coagulation after traumatic brain injury.

Authors:  Emily F Midura; Peter L Jernigan; Joshua W Kuethe; Lou Ann Friend; Rosalie Veile; Amy T Makley; Charles C Caldwell; Michael D Goodman
Journal:  J Surg Res       Date:  2015-03-05       Impact factor: 2.192

2.  Exosomal MicroRNAs in Military Personnel with Mild Traumatic Brain Injury: Preliminary Results from the Chronic Effects of Neurotrauma Consortium Biomarker Discovery Project.

Authors:  Christina Devoto; Chen Lai; Bao-Xi Qu; Vivian A Guedes; Jacqueline Leete; Elisabeth Wilde; William C Walker; Ramon Diaz-Arrastia; Kimbra Kenney; Jessica Gill
Journal:  J Neurotrauma       Date:  2020-07-02       Impact factor: 5.269

3.  Extracellular Vesicles in Neurological Disorders.

Authors:  Alex Mazurskyy; Jason Howitt
Journal:  Subcell Biochem       Date:  2021

Review 4.  ExRNA in Biofluids as Biomarkers for Brain Tumors.

Authors:  Robert C Rennert; Fred H Hochberg; Bob S Carter
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

Review 5.  MicroRNA Signature of Traumatic Brain Injury: From the Biomarker Discovery to the Point-of-Care.

Authors:  Valentina Di Pietro; Kamal M Yakoub; Ugo Scarpa; Cinzia Di Pietro; Antonio Belli
Journal:  Front Neurol       Date:  2018-06-14       Impact factor: 4.003

6.  Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control.

Authors:  Emerence Crompot; Michael Van Damme; Hugues Duvillier; Karlien Pieters; Marjorie Vermeesch; David Perez-Morga; Nathalie Meuleman; Philippe Mineur; Dominique Bron; Laurence Lagneaux; Basile Stamatopoulos
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

Review 7.  Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies.

Authors:  Kira S Sheinerman; Samuil R Umansky
Journal:  Front Cell Neurosci       Date:  2013-09-10       Impact factor: 5.505

8.  The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies.

Authors:  Lesley Cheng; Camelia Y J Quek; Xin Sun; Shayne A Bellingham; Andrew F Hill
Journal:  Front Genet       Date:  2013-08-08       Impact factor: 4.599

Review 9.  Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us?

Authors:  Matías Sáenz-Cuesta; Iñaki Osorio-Querejeta; David Otaegui
Journal:  Front Cell Neurosci       Date:  2014-03-28       Impact factor: 5.505

Review 10.  MicroRNAs as biomarkers for CNS disease.

Authors:  Pooja Rao; Eva Benito; André Fischer
Journal:  Front Mol Neurosci       Date:  2013-11-26       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.